Urogen Pharma (NASDAQ:URGN) Sees Strong Trading Volume After Analyst Upgrade
Shares of Urogen Pharma (NASDAQ:URGN – Get Free Report) saw unusually-high trading volume on Monday after HC Wainwright upgraded the stock from a neutral rating to a buy rating. HC Wainwright now has a $50.00 price target on the stock. Approximately 2,166,518 shares were traded during trading, an increase of 119% from the previous session’s […]
Shares of Urogen Pharma (NASDAQ:URGN – Get Free Report) saw unusually-high trading volume on Monday after HC Wainwright upgraded the stock from a neutral rating to a buy rating. HC Wainwright now has a $50.00 price target on the stock. Approximately 2,166,518 shares were traded during trading, an increase of 119% from the previous session’s […]
